CAMP4 Therapeutics Corporation
General ticker "CAMP" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $177.0M (TTM average)
CAMP4 Therapeutics Corporation follows the US Stock Market performance with the rate: 25.6%.
Estimated limits based on current volatility of 5.3%: low 3.90$, high 4.33$
Factors to consider:
- Earnings expected soon, date: 2026-08-13 bmo
- Total employees count: 48 (-99.5%) as of 2025
- US accounted for 62.9% of revenue in the fiscal year ended 2023-02-28
- Top business risk factors: Need for additional capital, Operational and conduct risks, Clinical trial failure, Regulatory and compliance, Market acceptance
- Price in estimated range
- Earnings for 3 months up through Q1 exceed our estimates
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [3.38$, 9.66$]
- 2026-12-31 to 2027-12-31 estimated range: [2.32$, 6.97$]
Short-term CAMP quotes
Long-term CAMP plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $0.65MM | $3.50MM |
| Operating Expenses | $53.74MM | $56.05MM |
| Operating Income | $-53.09MM | $-52.55MM |
| Non-Operating Income | $1.30MM | $-27.85MM |
| R&D Expense | $38.82MM | $38.20MM |
| Income(Loss) | $-51.79MM | $-80.40MM |
| Net Income(Loss)* | $-51.79MM | $-80.40MM |
| Stockholders Equity | $63.14MM | $47.70MM |
| Assets | $78.31MM | $117.81MM |
| Operating Cash Flow | $-45.56MM | $-29.55MM |
| Capital expenditure | $0.44MM | $0.28MM |
| Investing Cash Flow | $-0.44MM | $-0.24MM |
| Financing Cash Flow | $71.66MM | $75.89MM |
| Earnings Per Share** | $-2.66 | $-2.65 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.